Video

Dr. Jennifer Miles-Thomas discusses the gender pay gap in urology

Author(s):

Urology Times staff
Conference|LUGPA Annual Meeting
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      At the 2021 LUGPA Annual Meeting Jennifer Miles-Thomas, MD, FPMRS, president, Urology Of Virginia, participated in a panel discussion titled, “Strategies to Recruit and Retain Female Urologists in your Practice.” In this video, Miles-Thomas discusses the gender pay gap in urology.

      Related Videos
      Doctor consulting patient | Image Credit: © Liudmila Dutko - stock.adobe.com
      Why a personalized approach is key to prolapse and OAB management
      Anna Myers, CNP, answers a question during a Zoom video interview
      Anna Myers, CNP, on the overlap between urological and gynecological conditions
      Gopa Iyer, MD, highlights findings from FORAGER-1 in metastatic urothelial carcinoma
      Gopa Iyer, MD, highlights findings from FORAGER-1 in metastatic urothelial carcinoma
      Michael Schweizer, MD, shares data on mevrometostat plus enzalutamide in mCRPC
      Michael Schweizer, MD, shares data on mevrometostat plus enzalutamide in mCRPC
      Laura Bukavina, MD, highlights study of urinary microbiome profiling
      Laura Bukavina, MD, highlights study of urinary microbiome profiling
      Kate Gessner, MD, on the mechanisms of immunotherapy failure in RCC
      Kate Gessner, MD, on the mechanisms of immunotherapy failure in RCC
      Darren Feldman, MD, on clinical outcomes in R/R testicular germ cell tumors
      Darren Feldman, MD, on clinical outcomes in R/R testicular germ cell tumors
      ASCO GU recap: Insights on 5 key trials
      ASCO GU recap: Insights on 5 key trials
      Laurence Albiges, MD, on COSMIC-313 trial of triplet vs doublet combination in aRCC
      Laurence Albiges, MD, on COSMIC-313 trial of triplet vs doublet combination in aRCC
      Francesca Jackson-Spence, MRCP, on efficacy of savolitinib/durvalumab in papillary renal cancer
      Francesca Jackson-Spence, MRCP, on efficacy of savolitinib/durvalumab in papillary renal cancer
      Related Content
      Hospital waiting room with reception counter at medical facility | Image Credit: © visoot - stock.adobe.com
      April 5th 2025

      Vaginal prolapse repair and sling surgery significantly reduce UUI

      Christina M. Mezes, DO Catherine A. Matthews, MD
      "The biggest message from this study is that 60% can expect resolution of UUI, simply by fixing the prolapse and placing a sling, which is not normally indicated for UUI," according to Christina M. Mezes, DO, and Catherine A. Matthews, MD.
      Former MLB player Dave Winfield shares lessons from baseball, philanthropy
      November 15th 2024

      Former MLB player Dave Winfield shares lessons from baseball, philanthropy

      Urology Times staff
      In this episode of Speaking of Urology, former MLB player Dave Winfield shares lessons he’s learned throughout his professional baseball career and his work in philanthropy.
      FDA grants marketing authorization to at-home diagnostic test for STIs
      March 28th 2025

      FDA grants marketing authorization to at-home diagnostic test for STIs

      Hannah Clarke
      The test can deliver diagnostic results for chlamydia, gonorrhea, and trichomoniasis.
      Speaking of Urology: Dr. Winter on the use of vaginal estrogen
      July 24th 2024

      Speaking of Urology: Dr. Winter on the use of vaginal estrogen

      Urology Times staff
      In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
      FDA approves gepotidacin for uncomplicated UTI
      March 25th 2025

      FDA approves gepotidacin for uncomplicated UTI

      Hannah Clarke
      The approval is supported by data from the phase 3 EAGLE-2 and EAGLE-3 trials.
      Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome
      March 11th 2025

      Study progresses of sunobinop for interstitial cystitis/bladder pain syndrome

      Hannah Clarke
      "The findings from this study will help us understand sunobinop’s potential as a possible new treatment option for this chronic disorder,” said Craig Landau, MD.
      © 2025 MJH Life Sciences

      All rights reserved.